Thompson Siegel & Walmsley LLC Teva Pharmaceutical Industries LTD Transaction History

Thompson Siegel & Walmsley LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 09, 2018	SELL	$11.23 - $19.1 $18 Million - $30.7 Million	-1,606,255 Closed	0 $0
Q3 2017 Nov 08, 2017	SELL	$15.41 - $32.17 $12.6 Million - $26.3 Million	-816,227 Reduced 33.69%	1,606,255 $28.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	2,422,482	2,422,482 $80.5 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.